Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Athersys Inc (NASDAQ:ATHX)

1.50
Delayed Data
As of Apr 25
 0.00 / 0.00%
Today’s Change
1.02
Today|||52-Week Range
2.60
-1.96%
Year-to-Date
No recent news for Athersys Inc.

Today’s Trading

Previous close1.50
Today’s open1.51
Day’s range1.49 - 1.53
Volume757,118
Average volume (3 months)1,249,586
Market cap$164.7M
Dividend yield--
Data as of 3:59pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)+10.00%
Earnings growth (this year)-62.96%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+45.19%
P/E ratioNM
Price/Sales7.47
Price/Book11.62

Competitors

 Today’s
change
Today’s
% change
FBIOFortress Biotech Inc+0.29+8.84%
COCPCocrystal Pharma Inc+0.04+15.22%
CURRCure Pharmaceutical ...-0.31-4.43%
NEOSNeos Therapeutics In...-0.05-0.70%
Data as of 3:59pm ET, 04/25/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$17.3M
Annual profit (last year)-$15.3M
Net profit margin-88.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Gil van Bokkelen
President, Chief Operating Officer &
Secretary
William B. J. Lehmann
Corporate headquarters
Cleveland, Ohio

Forecasts


Search for Jobs